ReportsnReports.com - IVD Market Research Bundle

March 5, 2012 - PRLog -- Published in 2010, this important resource still stands up in its market coverage and is still used by the top diagnostic companies for their business planning. Shara Rosen’s report offers a great value by covering every segment of in vitro diagnostics with reliable forecasts, unprecedented company coverage and expert analysis. Published in May 2008 with a preface for the current economy written December 2008 the report covers every area of in vitro diagnostics - point of care, hematology, core lab, microbiology and virology, cytology and histology, blood banking, molecular diagnostics and more. The report details trends including intense consolidation and molecular testing that are shaping this industry.
Personalized Medicine Diagnostics (Biomarkers and Other Individualized Therapy)
Published in 2012, this report provides solid market estimates of the most cutting-edge parts of the in vitro diagnostic markets. The discovery of biomarkers with proven utility has lead to new approaches to testing and the preparation for and better use of therapeutics. This report, written by Kalorama Diagnostic Analyst Shara Rosen, details the real market for testing to individualize a therapy to a patient. Included areas of testing are infectious disease, cancer, diabetes, blood banking and organ transplantation. In the course of describing successful commercialization strategies, Rosen provides plenty of real-world examples.
Emerging Regional Markets for IVD (Brazil, India, Russia, China)
Published in 2012, this report takes a realistic look at real revenues for IVD in fast-grown regional markets, including Brazil, India, China and Russia. There have been many predictions made about these markets. In this report Kalorama Information makes a realistic assessment.